A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis
Clinical trial NCT05939947 · COMPLETED
Trial details
- NCT number
- NCT05939947
- Sponsor
- Alentis Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2024-10-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.